Schedule 13D ownership disclosure

TRANSCODE THERAPEUTICS INC

Common Stock, par value $0.0001 per share · CUSIP: 89357L402

Event date: 2025-03-07

Filing-level shares
35,000
Percent of class
5%
  • Thomas Joseph TracyReported CIK 0002062715

    Shares: 35,000 · Class: 5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000897069-25-000668
Form type
SCHEDULE 13D
Filer
Tracy Thomas Joseph
CIK
CIK 2062715
Filed
Mar 20, 2025
Reporting period
Mar 07, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub